SWG Educational Activities
Recruitment trials
Recruitment is underway for the following trials:
- Trial on precision hematology: Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies (EXALT-2); ClinicalTrials.gov ID NCT04470947
- Trial evaluating ex vivo testing to predict sensitivity and outcome of venetoclax-azacitdine treated AML patients: Azacitidine in Combination with Low Dose Intensity Venetoclax in Patients With AML Including Explorative AML Profiling (LA-VenEx)
Recuitment has completed for the following trial:
- Trial evaluating ex vivo testing of venetoclax for AML: Study of Venetoclax in Combination with Azacytidine in AML Patients Selected Using Ex vivo Drug Sensitivity Screening (VenEx)
Standards for functional precision medicine project
Standards for functional precision medicine, a project initiated by the SWG on Precision Hematology, received a 2023 SWG Grant and is currently underway.
EHA2023
Dates and location
The EHA2023 Hybrid Congress took place from June 8–11, 2023, in Frankfurt, Germany, and online.
Sessions
- SWG on Precision Hematology session: ‘Precision hematology towards ‘n of one’ therapies’
- Science-in-Focus session: ‘Functional precision oncology for hematopoietic cancers’
AACR Annual Meeting 2023
Dates and location
The AACR Annual Meeting 2023 took place from April 14–19, 2023, in Orlando, USA. SWG members contributed to the event.
Session
A ‘Functional Precision Medicine in Oncology’ session took place, with contributions from SWG members.
HARMONY
HARMONY-related activities include:
- Participation in the IHI HARMONY Alliance project
- Involvement in the establishment of the HARMONY Alliance Foundation
Back